Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Sang Yu

Showing results (261-270 of 349) with videos related to

Pageof 35
Sort By:
Drug Metabolism and Pharmacokinetics|December 21, 2020
Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjectsSoyoung Lee, Yujin Lee, Andrew HyoungJin Kim, et al.
Basic & Clinical Pharmacology & Toxicology|May 9, 2009
Effects of Angelicae tenuissima radix, Angelicae dahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteersSoJeong Yi, Joo-Youn Cho, Kyoung Soo Lim, et al.
Journal of Proteome Research|January 17, 2013
Global metabolomics and targeted steroid profiling reveal that rifampin, a strong human PXR activator, alters endogenous urinary steroid markersBora Kim, Ju-Yeon Moon, Man Ho Choi, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2017
Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy VolunteersSoo Youn Jun, In Jin Jang, Seonghae Yoon, et al.
The Pharmacogenomics Journal|May 29, 2020
Oral absorption of voriconazole is affected by SLCO2B1 c.*396T>C genetic polymorphism in CYP2C19 poor metabolizersSang Won Lee, Jaeseong Oh, Andrew HyoungJin Kim, et al.
Drug Metabolism and Pharmacokinetics|December 21, 2020
The utility of CYP3A activity endogenous markers for evaluating drug-drug interaction between sildenafil and CYP3A inhibitors in healthy subjectsSoyoung Lee, Andrew HyoungJin Kim, Sumin Yoon, et al.
Drug Design, Development and Therapy|October 11, 2014
Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjectsYu-Jung Cha, Kyoung Soo Lim, Min-Kyu Park, et al.
British Journal of Clinical Pharmacology|May 12, 2012
Apple juice greatly reduces systemic exposure to atenololHyewon Jeon, In-Jin Jang, SeungHwan Lee, et al.
Pediatric Hematology and Oncology|November 13, 2015
The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal InfectionsHyun Mi Kang, Hoan Jong Lee, Eun Young Cho, et al.
Clinical Therapeutics|January 30, 2010
The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: an open-label, one-sequence, three-period, three-treatment crossover studyKwang-Hee Shin, Bo-Hyung Kim, Tae-Eun Kim, et al.
Pageof 35

Showing results (261-270 of 349) with videos related to

Sort By:
Pageof 35
Drug Metabolism and Pharmacokinetics|December 21, 2020
Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjectsSoyoung Lee, Yujin Lee, Andrew HyoungJin Kim, et al.
Basic & Clinical Pharmacology & Toxicology|May 9, 2009
Effects of Angelicae tenuissima radix, Angelicae dahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteersSoJeong Yi, Joo-Youn Cho, Kyoung Soo Lim, et al.
Journal of Proteome Research|January 17, 2013
Global metabolomics and targeted steroid profiling reveal that rifampin, a strong human PXR activator, alters endogenous urinary steroid markersBora Kim, Ju-Yeon Moon, Man Ho Choi, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2017
Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy VolunteersSoo Youn Jun, In Jin Jang, Seonghae Yoon, et al.
The Pharmacogenomics Journal|May 29, 2020
Oral absorption of voriconazole is affected by SLCO2B1 c.*396T>C genetic polymorphism in CYP2C19 poor metabolizersSang Won Lee, Jaeseong Oh, Andrew HyoungJin Kim, et al.
Drug Metabolism and Pharmacokinetics|December 21, 2020
The utility of CYP3A activity endogenous markers for evaluating drug-drug interaction between sildenafil and CYP3A inhibitors in healthy subjectsSoyoung Lee, Andrew HyoungJin Kim, Sumin Yoon, et al.
Drug Design, Development and Therapy|October 11, 2014
Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjectsYu-Jung Cha, Kyoung Soo Lim, Min-Kyu Park, et al.
British Journal of Clinical Pharmacology|May 12, 2012
Apple juice greatly reduces systemic exposure to atenololHyewon Jeon, In-Jin Jang, SeungHwan Lee, et al.
Pediatric Hematology and Oncology|November 13, 2015
The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal InfectionsHyun Mi Kang, Hoan Jong Lee, Eun Young Cho, et al.
Clinical Therapeutics|January 30, 2010
The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: an open-label, one-sequence, three-period, three-treatment crossover studyKwang-Hee Shin, Bo-Hyung Kim, Tae-Eun Kim, et al.
Pageof 35